MapLight Therapeutics, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 7.72 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 429.04M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous system disorders. The company’s products include ML-007C-MA, a fixed-dose combination of an M 1 /M 4 muscarinic agonist for the treatment of schizophrenia and Alzheimer’s disease psychosis; ML-004 for the treatment of social communication deficit and/or irritability in autism spectrum disorder; ML-021 for the treatment of motor deficits in Parkinson’s disease; ML-055 for the treatment of neuropsychiatric conditions; and ML-009, a G-protein-coupled receptor 52 positive allosteric modulator for the treatment of hyperactivity, impulsivity and agitation-related disorders. The company also develops platform identifying neural circuits causally linked to disease and targeting those circuits for therapeutic modulation. The company was formerly known as Alvarado Therapeutics, Inc. and changed its name to MapLight Therapeutics, Inc. in August 2019. MapLight Therapeutics, Inc. was incorporated in 2018 and is based in Redwood City, California.
Details
| Name | MapLight Therapeutics, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 133 |
| Founded | 2018 |
| Ipo Date | 2025-10-27 |
| Ceo | Christopher Kroeger |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 17.00 |
| Isin | US56565P1030 |
| Cusip | 56565P103 |
| Cik | 1770069 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Dr. Christopher A. Kroeger M.B.A., M.D., Ph.D. | Founder, President, Chief Executive Officer and Director |
| Dr. Robert C. Malenka M.D., Ph.D. | Co-Founder and Member of Scientific Advisory Board |
| Dr. Erin Pennock Foff M.D., Ph.D. | Chief Medical Officer |
| Dr. Karoly Nikolich Ph.D. | Founder and Member of Advisory Board |
| Dr. Karl Deisseroth M.D., Ph.D. | Co-Founder and Member of Scientific Advisory Board |
| Jonathan Gillis CPA | Chief Admin and Acc Officer, PAO, Interim Chief Financial Officer & PFO |
| Dr. James Woodruff Lillie Ph.D. | Chief Scientific Officer |
| Kristopher L. Hanson J.D. | General Counsel and Secretary |
| Dr. Anatol Kreitzer Ph.D. | Chief Discovery Officer |
Contact
| Address | 800 Chesapeake Drive, Redwood City, California 94063, United States |
| Phone | 617 984 6300 |
| Website | https://www.maplightrx.com |